Logo image of ABN.AS

ABN AMRO BANK NV-CVA (ABN.AS) Stock Fundamental Analysis

Europe - Euronext Amsterdam - AMS:ABN - NL0011540547

29.21 EUR
+0.66 (+2.31%)
Last: 11/26/2025, 7:00:00 PM
Fundamental Rating

2

Taking everything into account, ABN scores 2 out of 10 in our fundamental rating. ABN was compared to 108 industry peers in the Banks industry. ABN has a bad profitability rating. Also its financial health evaluation is rather negative. ABN has a expensive valuation and it also scores bad on growth. Finally ABN also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year ABN was profitable.
In the past year ABN has reported a negative cash flow from operations.
Of the past 5 years ABN 4 years were profitable.
In multiple years ABN reported negative operating cash flow during the last 5 years.
ABN.AS Yearly Net Income VS EBIT VS OCF VS FCFABN.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B 20B 30B 40B

1.2 Ratios

ABN has a worse Return On Assets (0.52%) than 63.89% of its industry peers.
ABN has a worse Return On Equity (7.80%) than 66.67% of its industry peers.
Industry RankSector Rank
ROA 0.52%
ROE 7.8%
ROIC N/A
ROA(3y)0.58%
ROA(5y)0.4%
ROE(3y)9.1%
ROE(5y)6.35%
ROIC(3y)N/A
ROIC(5y)N/A
ABN.AS Yearly ROA, ROE, ROICABN.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4 6 8 10

1.3 Margins

The Profit Margin of ABN (22.73%) is comparable to the rest of the industry.
ABN's Profit Margin has improved in the last couple of years.
The Operating Margin and Gross Margin are not available for ABN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 22.73%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y26.68%
PM growth 5Y4.95%
GM growth 3YN/A
GM growth 5YN/A
ABN.AS Yearly Profit, Operating, Gross MarginsABN.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20 25

1

2. Health

2.1 Basic Checks

ABN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ABN has less shares outstanding
Compared to 5 years ago, ABN has less shares outstanding
Compared to 1 year ago, ABN has a worse debt to assets ratio.
ABN.AS Yearly Shares OutstandingABN.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
ABN.AS Yearly Total Debt VS Total AssetsABN.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100B 200B 300B 400B

2.2 Solvency

ABN has a Debt/Equity ratio of 2.67. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 2.67, ABN is doing worse than 64.81% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 2.67
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC9.47%
ABN.AS Yearly LT Debt VS Equity VS FCFABN.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B 60B 80B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
ABN.AS Yearly Current Assets VS Current LiabilitesABN.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

3

3. Growth

3.1 Past

ABN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -14.29%.
The Earnings Per Share has been growing slightly by 5.46% on average over the past years.
Looking at the last year, ABN shows a small growth in Revenue. The Revenue has grown by 2.67% in the last year.
ABN shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.59% yearly.
EPS 1Y (TTM)-14.29%
EPS 3Y30.68%
EPS 5Y5.46%
EPS Q2Q%-14.1%
Revenue 1Y (TTM)2.67%
Revenue growth 3Y-0.5%
Revenue growth 5Y-1.59%
Sales Q2Q%-3.73%

3.2 Future

The Earnings Per Share is expected to grow by 6.85% on average over the next years.
ABN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.70% yearly.
EPS Next Y-4.14%
EPS Next 2Y1.75%
EPS Next 3Y6.48%
EPS Next 5Y6.85%
Revenue Next Year0.43%
Revenue Next 2Y2.82%
Revenue Next 3Y3.2%
Revenue Next 5Y2.7%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ABN.AS Yearly Revenue VS EstimatesABN.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B 8B 10B
ABN.AS Yearly EPS VS EstimatesABN.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 1 2 3

3

4. Valuation

4.1 Price/Earnings Ratio

ABN is valuated reasonably with a Price/Earnings ratio of 11.87.
Based on the Price/Earnings ratio, ABN is valued a bit more expensive than 64.81% of the companies in the same industry.
ABN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.15.
Based on the Price/Forward Earnings ratio of 10.45, the valuation of ABN can be described as reasonable.
ABN's Price/Forward Earnings is on the same level as the industry average.
ABN is valuated cheaply when we compare the Price/Forward Earnings ratio to 36.12, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 11.87
Fwd PE 10.45
ABN.AS Price Earnings VS Forward Price EarningsABN.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ABN.AS Per share dataABN.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)2.18
EPS Next 2Y1.75%
EPS Next 3Y6.48%

7

5. Dividend

5.1 Amount

ABN has a Yearly Dividend Yield of 4.80%, which is a nice return.
Compared to an average industry Dividend Yield of 4.85, ABN has a dividend in line with its industry peers.
ABN's Dividend Yield is rather good when compared to the S&P500 average which is at 2.41.
Industry RankSector Rank
Dividend Yield 4.8%

5.2 History

The dividend of ABN has a limited annual growth rate of 0.22%.
Dividend Growth(5Y)0.22%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

52.45% of the earnings are spent on dividend by ABN. This is a bit on the high side, but may be sustainable.
The dividend of ABN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP52.45%
EPS Next 2Y1.75%
EPS Next 3Y6.48%
ABN.AS Yearly Income VS Free CF VS DividendABN.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B 20B 30B 40B
ABN.AS Dividend Payout.ABN.AS Dividend Payout, showing the Payout Ratio.ABN.AS Dividend Payout.PayoutRetained Earnings

ABN AMRO BANK NV-CVA

AMS:ABN (11/26/2025, 7:00:00 PM)

29.21

+0.66 (+2.31%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)11-12 2025-11-12/bmo
Earnings (Next)02-11 2026-02-11/amc
Inst Owners45.48%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap17.64B
Revenue(TTM)9.54B
Net Income(TTM)2.15B
Analysts73.33
Price Target29.4 (0.65%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.8%
Yearly Dividend1.46
Dividend Growth(5Y)0.22%
DP52.45%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.19%
Min EPS beat(2)2.08%
Max EPS beat(2)2.3%
EPS beat(4)3
Avg EPS beat(4)6.3%
Min EPS beat(4)-2.93%
Max EPS beat(4)23.76%
EPS beat(8)7
Avg EPS beat(8)16.15%
EPS beat(12)11
Avg EPS beat(12)44.38%
EPS beat(16)15
Avg EPS beat(16)56%
Revenue beat(2)0
Avg Revenue beat(2)-2.01%
Min Revenue beat(2)-2.68%
Max Revenue beat(2)-1.33%
Revenue beat(4)2
Avg Revenue beat(4)-0.07%
Min Revenue beat(4)-2.68%
Max Revenue beat(4)1.9%
Revenue beat(8)5
Avg Revenue beat(8)0.46%
Revenue beat(12)9
Avg Revenue beat(12)4.89%
Revenue beat(16)13
Avg Revenue beat(16)7.85%
PT rev (1m)11.74%
PT rev (3m)17.93%
EPS NQ rev (1m)-1.28%
EPS NQ rev (3m)0.7%
EPS NY rev (1m)-0.76%
EPS NY rev (3m)0.23%
Revenue NQ rev (1m)-0.74%
Revenue NQ rev (3m)-0.48%
Revenue NY rev (1m)-0.26%
Revenue NY rev (3m)-0.27%
Valuation
Industry RankSector Rank
PE 11.87
Fwd PE 10.45
P/S 1.87
P/FCF N/A
P/OCF N/A
P/B 0.64
P/tB 0.65
EV/EBITDA N/A
EPS(TTM)2.46
EY8.42%
EPS(NY)2.8
Fwd EY9.57%
FCF(TTM)-2.24
FCFYN/A
OCF(TTM)-1.53
OCFYN/A
SpS15.62
BVpS45.5
TBVpS45.02
PEG (NY)N/A
PEG (5Y)2.18
Graham Number50.19
Profitability
Industry RankSector Rank
ROA 0.52%
ROE 7.8%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 22.73%
GM N/A
FCFM N/A
ROA(3y)0.58%
ROA(5y)0.4%
ROE(3y)9.1%
ROE(5y)6.35%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y26.68%
PM growth 5Y4.95%
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 2.67
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 268.55%
Cap/Sales 4.53%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score2
WACC9.47%
ROIC/WACCN/A
Cap/Depr(3y)169.11%
Cap/Depr(5y)137.34%
Cap/Sales(3y)3.36%
Cap/Sales(5y)2.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-14.29%
EPS 3Y30.68%
EPS 5Y5.46%
EPS Q2Q%-14.1%
EPS Next Y-4.14%
EPS Next 2Y1.75%
EPS Next 3Y6.48%
EPS Next 5Y6.85%
Revenue 1Y (TTM)2.67%
Revenue growth 3Y-0.5%
Revenue growth 5Y-1.59%
Sales Q2Q%-3.73%
Revenue Next Year0.43%
Revenue Next 2Y2.82%
Revenue Next 3Y3.2%
Revenue Next 5Y2.7%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y93.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y95.61%
OCF growth 3YN/A
OCF growth 5YN/A

ABN AMRO BANK NV-CVA / ABN.AS FAQ

Can you provide the ChartMill fundamental rating for ABN AMRO BANK NV-CVA?

ChartMill assigns a fundamental rating of 2 / 10 to ABN.AS.


What is the valuation status of ABN AMRO BANK NV-CVA (ABN.AS) stock?

ChartMill assigns a valuation rating of 3 / 10 to ABN AMRO BANK NV-CVA (ABN.AS). This can be considered as Overvalued.


Can you provide the profitability details for ABN AMRO BANK NV-CVA?

ABN AMRO BANK NV-CVA (ABN.AS) has a profitability rating of 2 / 10.


How financially healthy is ABN AMRO BANK NV-CVA?

The financial health rating of ABN AMRO BANK NV-CVA (ABN.AS) is 1 / 10.


Is the dividend of ABN AMRO BANK NV-CVA sustainable?

The dividend rating of ABN AMRO BANK NV-CVA (ABN.AS) is 7 / 10 and the dividend payout ratio is 52.45%.